Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Organoid Culture

Items 1-10 of 108

Page
per page
  1. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     81 Citation
    Target: ROCK
    Summary: ROCK inhibitor
      ≥111.2 mg/mL
  2. SB 431542
    A8249 SB 431542
     30 Citation
    Summary: ALK5 inhibitor
  3. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     21 Citation
    Target: p38
    Summary: A potent and selective MAPK inhibitor.
  4. Forskolin
    B1421 Forskolin
     19 Citation
    Target: Adenylyl Cyclases
    Summary: type I adenylate cyclase agonist
  5. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     32 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor
      ≥23.27 mg/mL
  6. Recombinant Human LR3 IGF-1 (Media Grade)
    P1145 Recombinant Human LR3 IGF-1 (Media Grade)
    Summary: Recombinant Human LR3 IGF-1 (Media Grade) (E.coli, Tag Free, Lyophilized)
  7. Gastrin I (human)
    B5358 Gastrin I (human)
    Summary: selective CCK2 receptor agonist
      insoluble in H2O; insoluble in EtOH; ≥21 mg/mL
  8. Prostaglandin E2
    B7005 Prostaglandin E2
     3 Citation
    Target: Prostaglandin EP receptors
    Summary: An endogenous prostaglandin, commonly used to construct PGE2-induced hyperalgesia/allodynia (intrathecal injection) and inflammation-related bone loss animal models.
      ≥35.2 mg/mL
  9. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     21 Citation
    Summary: A γ-secretase inhibitor.
      ≥21.62 mg/mL
  10. Acetylcysteine
    A8356 Acetylcysteine
     11 Citation
    Summary: Antioxidant;mucolytic agent
      ≥44.6 mg/mL

Items 1-10 of 108

Page
per page